DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66,355,000 | +105.5% | 250,000 | +100.0% | 5.97% | +103.4% |
| Q3 2022 | $32,286,000 | -57.5% | 125,000 | -58.3% | 2.94% | -46.1% |
| Q2 2022 | $76,056,000 | -56.8% | 300,000 | -50.0% | 5.44% | -0.2% |
| Q1 2022 | $175,998,000 | +1.9% | 600,000 | +14.3% | 5.46% | +63.4% |
| Q4 2021 | $172,730,000 | +13.5% | 525,000 | +5.0% | 3.34% | +28.2% |
| Q3 2021 | $152,220,000 | +13.4% | 500,000 | 0.0% | 2.60% | +2.2% |
| Q2 2021 | $134,180,000 | +138.5% | 500,000 | +100.0% | 2.55% | +120.2% |
| Q1 2021 | $56,270,000 | +1.3% | 250,000 | 0.0% | 1.16% | +10.3% |
| Q4 2020 | $55,535,000 | -35.5% | 250,000 | -37.5% | 1.05% | -58.2% |
| Q3 2020 | $86,132,000 | +8.2% | 400,000 | -11.1% | 2.51% | -8.7% |
| Q2 2020 | $79,574,000 | -8.2% | 450,000 | -25.0% | 2.75% | +26.5% |
| Q3 2019 | $86,658,000 | -26.5% | 600,000 | -27.3% | 2.17% | +0.4% |
| Q2 2019 | $117,909,000 | -25.6% | 825,000 | -31.2% | 2.17% | -39.4% |
| Q1 2019 | $158,424,000 | -58.9% | 1,200,000 | -73.3% | 3.57% | +6.5% |
| Q2 2015 | $385,155,000 | +65.0% | 4,500,000 | +63.6% | 3.35% | +49.6% |
| Q1 2015 | $233,475,000 | -41.0% | 2,750,000 | -40.5% | 2.24% | -46.7% |
| Q4 2014 | $395,980,000 | +6.4% | 4,620,000 | -5.7% | 4.20% | +8.1% |
| Q3 2014 | $372,302,000 | +5.1% | 4,900,000 | +8.9% | 3.89% | +4.4% |
| Q2 2014 | $354,285,000 | +18.1% | 4,500,000 | +12.5% | 3.72% | +4.3% |
| Q1 2014 | $300,000,000 | +3.6% | 4,000,000 | +6.7% | 3.57% | +7.4% |
| Q4 2013 | $289,500,000 | +11.4% | 3,750,000 | 0.0% | 3.32% | -11.3% |
| Q3 2013 | $259,950,000 | +2.7% | 3,750,000 | -6.2% | 3.75% | -4.9% |
| Q2 2013 | $253,200,000 | – | 4,000,000 | – | 3.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |